Pulse Biosciences, Inc. (PLSE) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 71.13M | 83.42M | 97.16M | 108.16M | 120.91M | 119.45M | 80.41M | 27.24M | 35.85M | 45.33M | 51.62M | 59.96M |
| Cash & Short-Term Investments | 68.32M | 80.73M | 95.21M | 106.35M | 119.28M | 118.04M | 79.03M | 26.2M | 34.88M | 44.37M | 50.39M | 58.75M |
| Cash Only | 68.32M | 80.73M | 95.21M | 106.35M | 119.28M | 118.04M | 79.03M | 26.2M | 34.88M | 44.37M | 50.39M | 58.75M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 157K | 274K | 15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 48.37 | 50.36 | 16.05 | - | - | - | - | - | - | - | - | - |
| Inventory | 206K | 136K | 57K | 51K | 30K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 41.59 | 17.11 | 17.81 | 13.8 | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.45M | 2.28M | 0 | 1.76M | 1.6M | 1.41M | 1.38M | 1.04M | 964K | 963K | 1.24M | 1.21M |
| Total Non-Current Assets | 10.49M | 12.69M | 11.61M | 12.09M | 12.47M | 13.01M | 12.63M | 13.19M | 13.31M | 13.83M | 14.32M | 14.8M |
| Property, Plant & Equipment | 6.72M | 7.06M | 7.37M | 7.72M | 7.95M | 8.32M | 7.81M | 8.13M | 8.44M | 8.78M | 9.11M | 9.43M |
| Fixed Asset Turnover | 0.06x | 0.04x | 0.01x | - | - | - | - | - | - | - | - | - |
| Goodwill | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Intangible Assets | 408K | 575K | 741K | 907K | 1.05M | 1.22M | 1.39M | 1.55M | 1.72M | 1.89M | 2.05M | 2.22M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 575K | 691K | 705K | 677K | 678K | 677K | 646K | 714K | 365K | 365K | 365K | 365K |
| Total Assets | 81.62M | 96.11M | 108.77M | 120.25M | 133.38M | 132.46M | 93.05M | 40.43M | 49.16M | 59.15M | 65.94M | 74.76M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -38.81% | -27.44% | 16.89% | 197.44% | 171.3% | 123.92% | 41.1% | -45.92% | -29.99% | -24.04% | -24.69% | 84.14% |
| Total Current Liabilities | 9.8M | 7.92M | 9.7M | 8.98M | 7.76M | 10.05M | 6.74M | 5.96M | 5.08M | 6.71M | 5.43M | 5.61M |
| Accounts Payable | 2.76M | 2.78M | 2.98M | 2.74M | 2.37M | 1.67M | 1.73M | 1.64M | 1.71M | 1.84M | 1.41M | 1.79M |
| Days Payables Outstanding | 673.54 | 510.08 | 943.08 | 871.15 | - | - | - | - | 539.91 | - | - | - |
| Short-Term Debt | 1.63M | 1.57M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.41M | 1.6M | 0 | 3.47M | 2.68M | 1.2M | 3.11M | 2.68M | 1.78M | 3.2M | 2.25M | 2.12M |
| Current Ratio | 7.26x | 10.53x | 10.02x | 12.05x | 15.58x | 11.88x | 11.93x | 4.57x | 7.06x | 6.76x | 9.50x | 10.68x |
| Quick Ratio | 7.24x | 10.51x | 10.01x | 12.04x | 15.58x | 11.88x | 11.93x | 4.57x | 7.06x | 6.76x | 9.50x | 10.68x |
| Cash Conversion Cycle | -583.58 | -442.62 | -909.23 | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 5.53M | 7.54M | 6.37M | 6.79M | 7.17M | 7.54M | 7.17M | 7.5M | 7.8M | 8.09M | 8.37M | 8.64M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 5.53M | 5.96M | 6.37M | 6.79M | 7.17M | 7.54M | 7.17M | 7.5M | 7.8M | 8.09M | 8.37M | 8.64M |
| Deferred Tax Liabilities | 0 | 1.57M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 15.32M | 15.46M | 16.07M | 15.76M | 14.93M | 17.6M | 13.91M | 13.46M | 12.88M | 14.79M | 13.8M | 14.26M |
| Total Debt | 7.16M | 7.53M | 7.89M | 8.24M | 8.58M | 8.9M | 8.37M | 8.64M | 8.9M | 9.14M | 9.38M | 9.62M |
| Net Debt | -61.16M | -73.2M | -87.32M | -98.1M | -110.7M | -109.14M | -70.67M | -17.55M | -25.99M | -35.22M | -41M | -49.13M |
| Debt / Equity | 0.11x | 0.09x | 0.09x | 0.08x | 0.07x | 0.08x | 0.11x | 0.32x | 0.25x | 0.21x | 0.18x | 0.16x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 66.3M | 80.66M | 92.69M | 104.49M | 118.45M | 114.86M | 79.13M | 26.97M | 36.29M | 44.36M | 52.15M | 60.5M |
| Equity Growth % | -44.03% | -29.78% | 17.14% | 287.43% | 226.43% | 158.93% | 51.75% | -55.42% | 440.15% | 2073.31% | 742.54% | 158.38% |
| Book Value per Share | 0.98 | 1.20 | 1.38 | 1.55 | 1.76 | 1.97 | 1.30 | 0.47 | 0.66 | 0.81 | 0.95 | 1.36 |
| Total Shareholders' Equity | 66.3M | 80.66M | 92.69M | 104.49M | 118.45M | 114.86M | 79.13M | 26.97M | 36.29M | 44.36M | 52.15M | 60.5M |
| Common Stock | 68K | 68K | 68K | 67K | 67K | 66K | 62K | 55K | 55K | 55K | 55K | 55K |
| Retained Earnings | -481.86M | -463.28M | -445.85M | -426.46M | -407.3M | -390.5M | -371.12M | -358.44M | -347.05M | -336.92M | -324.98M | -314.42M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |